Drug Shortage Report for VIRAZOLE

Last updated on 2021-08-12 History
Report ID 134795
Drug Identification Number 02170140
Brand name VIRAZOLE
Common or Proper name VIRAZOLE
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) RIBAVIRIN
Strength(s) 6G
Dosage form(s) AEROSOL POWDER FOR SOLUTION
Route of administration INHALATION INHALATION
Packaging size n/a
ATC code J05AP
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-07-31
Actual start date
Estimated end date 2021-09-21
Actual end date 2021-08-11
Shortage status Resolved
Updated date 2021-08-12
Company comments Registration of New API Supplier
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2021-08-12 French Compare
v14 2021-08-12 English Compare
v13 2021-08-01 English Compare
v12 2021-07-16 French Compare
v11 2021-07-16 English Compare
v10 2021-07-02 French Compare
v9 2021-04-01 French Compare
v8 2021-04-01 English Compare
v7 2021-03-23 English Compare
v6 2021-03-18 French Compare
v5 2021-03-18 English Compare
v4 2021-03-02 English Compare
v3 2021-02-26 French Compare
v2 2021-02-26 English Compare
v1 2021-02-26 English Compare

Showing 1 to 15 of 15